GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001 per share) At The Market Issuance Sales AgreementGalectin Therapeutics Inc • May 11th, 2020 • Pharmaceutical preparations • New York
Company FiledMay 11th, 2020 Industry JurisdictionGalectin Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with H.C. Wainwright & Co., LLC (“Wainwright”), as follows: